Cat.#: ASSD-221
Description | Antifade Fluorescence Mounting Medium with DAPI (hardset) from Ace Therapeutics is used to prevent the photobleaching of fluorescent proteins and dyes during fluorescent imaging. This product contains DAPI which is a blue fluorescent DNA stain used to label cell nuclei. |
Size | 10 mL |
Applications | Cellular imaging, IHC(IF), ICC |
Mounting | Aqueous (hardset) - cures in approximately 1 hour at RT |
Antifade | Yes |
Counterstain | DAPI |
Refractive index | ≈1.45 (initial) which then increases to ≈1.518 once cured |
Emission color | Blue |
Excitation | 350 nm |
Emission | 470 nm |
Closest laser lines | 405 nm |
Cell permeable | Yes |
Storage | +4°C or -20°C long-term. |
Shipping | Shipped at 4°C |
Important | If the mounting medium solidifies prematurely during operation, simply heat the bottle to approximately 60°C and the mounting medium will reliquefy. We strongly recommend storing this product in a storage buffer containing 0.05% sodium azide and away from light. |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ASSD-155 | Bromophenol blue (AC155) | 5g | inquiry |
ASSD-130 | Calcein-AM (AC130) | 1 mg | inquiry |
ASSD-198 | NHS-5(6)Carboxyrhodamine (AC198) | 25 mg | inquiry |
ASSD-146 | Pyronin Y (AC146) | 1 g, 5g | inquiry |
ASSD-179 | 8-Azidoadenosine-5′-diphosphate Sodium Salt (AC179) | 1 mg, 5 mg | inquiry |
ASSD-112 | Propidium Iodide Staining Solution (1mg/ml) in water (AC112) | 1 mL | inquiry |
ASSD-117 | Annexin V-PE Apoptosis Staining / Detection Kit (AC117) | 1 kit, 100 tests | inquiry |
ASSD-102 | DAPI (AC102) | 10 mg, 50 mg | inquiry |
ASSD-148 | Sulforhodamine 101 (AC148) | 50 mg, 100 mg | inquiry |
ASSD-135 | JC-1 (AC135) | 5 mg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.